IL-11 neutralising therapies for the treatment of nonalcoholic steatohepatitis

Accession: GSE128940
Source / host: GEO — NCBI GEO FTP
Disease relevance: MASLD / NAFLD / NASH (category: Transcriptomic, subtype: bulk RNA-seq)
Modality / assay: bulk-RNAseq
Platform: Expression profiling by high throughput sequencing, GPL18573;19057
Organism: human
Samples: 30
Size (indexed): 8.7 MB (9094050 bytes)
Downloaded bytes: 8.7 MB (9094050 bytes)
Access / raw: public / OPEN-raw

Download

Files

FileSizeSHA256
GSE128940_counts_human.txt.gz4.6 MB7657adaf9a8b9757…
GSE128940_counts_mouse.txt.gz4.1 MB8dcee88574188d84…

Index note: 2 suppl file(s); GSE128940_counts_human.txt.gz

Crawled by masld-atlas-crawler v1.0 at 2026-08-02T17:13:45Z.

About this dataset

This Expression profiling by high throughput sequencing, GPL18573;19057 dataset provides single-cell gene expression from human liver samples, with disease state recorded as MASLD/NAFLD/NASH. It profiles about 30 cells or nuclei.

Analyze it in Drylab

Open this dataset in Drylab and ask a question in plain language. The AI agent loads the files, runs the analysis in a ready sandbox and explains each result. A typical first pass:

  1. Load the filtered feature-barcode matrix (HDF5) and run quality control on counts, genes and mitochondrial reads per cell.
  2. Normalize, select variable genes, then cluster the cells and draw a UMAP.
  3. Annotate clusters with marker genes and compare the cell-type mix between conditions.
  4. Run differential expression between cell types or samples to characterize masld/nafld/nash biology.